Vanguard Group
IMNN icon

Vanguard Group’s Imunon IMNN Stock Holding History

Vanguard Group’s Portfolio IMNN Stock Details IMNN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$141K Buy
37,052
+13,751
+59% +$58.8K ﹤0.01% 4139
2025
Q3 		$120K Buy
23,301
+8,697
+60% +$58.1K ﹤0.01% 4204
2025
Q2 		$152K Buy
14,604
+10,862
+290% +$148K ﹤0.01% 4110
2025
Q1 		$51.2K Hold
3,742
– – ﹤0.01% 4191
2024
Q4 		$46.4K Hold
3,742
– – ﹤0.01% 4220
2024
Q3 		$51.7K Hold
3,742
– – ﹤0.01% 4245
2024
Q2 		$56.6K Hold
3,742
– – ﹤0.01% 4277
2024
Q1 		$80K Sell
3,742
-169
-4% -$1.61K ﹤0.01% 4262
2023
Q4 		$34.7K Sell
3,911
-5,431
-58% -$66.2K ﹤0.01% 4398
2023
Q3 		$120K Hold
9,342
– – ﹤0.01% 4325
2023
Q2 		$157K Buy
9,342
+170
+2% +$2.81K ﹤0.01% 4342
2023
Q1 		$148K Sell
9,172
-2,525
-22% -$48.5K ﹤0.01% 4362
2022
Q4 		$206K Buy
11,697
+9
+0.1% +$173 ﹤0.01% 4307
2022
Q3 		$256K Sell
11,688
-6,325
-35% -$178K ﹤0.01% 4378
2022
Q2 		$432K Hold
18,013
– – ﹤0.01% 4324
2022
Q1 		$1.19M Sell
18,013
-1,851
-9% -$145K ﹤0.01% 4154
2021
Q4 		$2.1M Sell
19,864
-63
-0.3% -$9.81K ﹤0.01% 4016
2021
Q3 		$3.6M Buy
19,927
+1,126
+6% +$234K ﹤0.01% 3833
2021
Q2 		$4.67M Buy
18,801
+2,841
+18% +$672K ﹤0.01% 3644
2021
Q1 		$4.31M Buy
15,960
+9,491
+147% +$3.19M ﹤0.01% 3604
2020
Q4 		$900K Sell
6,469
-21
-0.3% -$2.52K ﹤0.01% 3853
2020
Q3 		$930K Sell
6,490
-385
-6% -$97.3K ﹤0.01% 3670
2020
Q2 		$5M Buy
6,875
+3,197
+87% +$1.39M ﹤0.01% 3100
2020
Q1 		$651K Sell
3,678
-70
-2% -$17.5K ﹤0.01% 3614
2019
Q4 		$1.25M Hold
3,748
– – ﹤0.01% 3578
2019
Q3 		$1.13M Buy
3,748
+146
+4% +$50K ﹤0.01% 3620
2019
Q2 		$1.28M Buy
3,602
+1,083
+43% +$441K ﹤0.01% 3598
2019
Q1 		$966K Hold
2,519
– – ﹤0.01% 3631
2018
Q4 		$695K Sell
2,519
-1,264
-33% -$524K ﹤0.01% 3662
2018
Q3 		$2.05M Buy
3,783
+1,098
+41% +$605K ﹤0.01% 3517
2018
Q2 		$1.55M Buy
2,685
+12
+0.4% +$5.95K ﹤0.01% 3569
2018
Q1 		$1.17M Buy
2,673
+606
+29% +$292K ﹤0.01% 3613
2017
Q4 		$1.08M Buy
2,067
+1,327
+179% +$753K ﹤0.01% 3596
2017
Q3 		$217K Buy
740
+265
+56% +$81.6K ﹤0.01% 3898
2017
Q2 		$190K Buy
475
+173
+57% +$111K ﹤0.01% 3911
2017
Q1 		$239K Buy
302
+92
+44% +$79.1K ﹤0.01% 3875
2016
Q4 		$180K Hold
210
– – ﹤0.01% 3906
2016
Q3 		$703K Sell
210
-8
-4% -$27.3K ﹤0.01% 3672
2016
Q2 		$757K Hold
218
– – ﹤0.01% 3685
2016
Q1 		$871K Buy
218
+1
+0.5% +$3.8K ﹤0.01% 3637
2015
Q4 		$1.14M Buy
217
+2
+0.9% +$10.3K ﹤0.01% 3579
2015
Q3 		$982K Buy
215
+4
+2% +$23.9K ﹤0.01% 3638
2015
Q2 		$1.35M Buy
211
+16
+8% +$114K ﹤0.01% 3569
2015
Q1 		$1.43M Buy
195
+9
+5% +$62.6K ﹤0.01% 3529
2014
Q4 		$1.19M Buy
186
+1
+0.5% +$6.94K ﹤0.01% 3470
2014
Q3 		$1.5M Sell
185
-10
-5% -$87.1K ﹤0.01% 3377
2014
Q2 		$1.86M Hold
195
– – ﹤0.01% 3286
2014
Q1 		$1.8M Buy
195
+21
+12% +$219K ﹤0.01% 3266
2013
Q4 		$1.85M Buy
174
+17
+11% +$204K ﹤0.01% 3217
2013
Q3 		$2.23M Buy
157
+18
+13% +$266K ﹤0.01% 3092
2013
Q2 		$1.75M Buy
+139
New +$1.93M ﹤0.01% 3113

Other funds holding IMNN

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
RCA
Riverview Capital Advisers Boston, Massachusetts $300M AUM 10.98% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Vanguard Group's IMNN Position: Q4 2025 in Review

Vanguard Group increased its Imunon (IMNN) stake by 59% in Q4 2025, buying an estimated $58.8K and bringing the position to 37,052 shares worth $141K. The position accounts for ﹤0.01% of the portfolio, ranked #4139.

Vanguard Group first reported a position in IMNN in Q2 2013 and has held it in 51 quarters since. The position peaked at $5M in Q2 2020. 20 funds tracked by Wall St. Rank hold IMNN as of Q4 2025.

  • Vanguard Group held 37,052 shares of Imunon worth $141K as of Q4 2025.
  • Vanguard Group bought 13,751 Imunon shares in Q4 2025, an estimated $58.8K.
  • Imunon made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4139 holding.
  • Vanguard Group first reported a position in Imunon in Q2 2013 and has held it in 51 quarters since.
  • Vanguard Group's Imunon position peaked at $5M in Q2 2020.
  • 20 funds tracked by Wall St. Rank held Imunon as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.